Mr. Keon, what percentage of the sales revenue of your participating companies is invested in research and development, to discover new and innovative medicines to benefit Canadian patients? Today, the discussion is about access to new and innovative medicines. My understanding is that the generic drug industry is really not involved in that discussion.
On April 16th, 2007. See this statement in context.